Cullinan Oncology Inc (CGEM)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre

Cours de l'action
Code mnémonique : CGEM Marché : NSM


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Résultats financiers
Résultats financiers
 
Value bought

90 derniers jours

 
Value sold

90 derniers jours

 
Net insiders buying

90 derniers jours

 
Trades (buy and sell)

90 derniers jours

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur Détails
2025-02-27 2025-02-25 V Vente

AHMED NADIM

President and CEO

Administrateur exécutif
12 529 -2.8%
8,53
106 872 USD 		12 529 -2.8% 8,53 106 872 USD
2025-02-27 2025-02-25 V Vente

Jones Jeffrey Alan

Chief Medical Officer

Dirigeant
4 895 -2.7%
8,53
41 754 USD 		4 895 -2.7% 8,53 41 754 USD
2025-02-27 2025-02-25 V Vente

SUMER JACQUELYN L

Chief Legal Officer

Dirigeant
3 756 -2.7%
8,53
32 039 USD 		3 756 -2.7% 8,53 32 039 USD
2025-02-27 2025-02-25 V Vente

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
3 756 -2.6%
8,53
32 039 USD 		3 756 -2.6% 8,53 32 039 USD
2025-01-07 2025-01-06 VP Vente planifiée

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
4 000 -4.0%
12,51
50 040 USD 		4 000 -4.0% 12,51 50 040 USD
2024-12-27 2024-12-24 V Vente

AHMED NADIM

President and CEO

Administrateur exécutif
8 400 -3.1%
11,87
99 708 USD 		8 400 -3.1% 11,87 99 708 USD
2024-12-20 2024-12-18 V Vente

SUMER JACQUELYN L

Chief Legal Officer

Dirigeant
3 482 -3.7%
11,41
39 730 USD 		3 482 -3.7% 11,41 39 730 USD
2024-12-20 2024-12-18 V Vente

Jones Jeffrey Alan

Chief Medical Officer

Dirigeant
4 632 -3.9%
11,41
52 851 USD 		4 632 -3.9% 11,41 52 851 USD
2024-12-20 2024-12-18 V Vente

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
4 693 -4.5%
11,41
53 547 USD 		4 693 -4.5% 11,41 53 547 USD
2024-12-16 2024-12-12 V Vente

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
3 489 -3.2%
12,52
43 682 USD 		3 489 -3.2% 12,52 43 682 USD
2024-11-07 2024-11-05 VP Vente planifiée

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
8 000 -6.9%
15,64
125 120 USD 		8 000 -6.9% 15,64 125 120 USD
2024-09-09 2024-09-05 VP Vente planifiée

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
8 000 -6.5%
18,09
144 720 USD 		8 000 -6.5% 18,09 144 720 USD
2024-07-09 2024-07-05 VP Vente planifiée

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
8 000 -6.1%
16,33
130 640 USD 		8 000 -6.1% 16,33 130 640 USD
2024-05-08 2024-05-07 VP Vente planifiée

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
5 606 -4.1%
30,06
168 516 USD 		5 606 -4.1% 30,06 168 516 USD
2024-05-08 2024-05-06 VP Vente planifiée

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
20 277 -13.5%
28,54
578 706 USD 		20 277 -13.5% 28,54 578 706 USD
2024-05-08 2024-05-06 VP Vente planifiée

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
37 723 -20.1%
27,82
1 049 454 USD 		37 723 -20.1% 27,82 1 049 454 USD
2024-02-02 2024-02-01 VP Vente planifiée

Savill Corrine

Chief Business Officer

Dirigeant
40 000 -19.4%
16,18
647 200 USD 		40 000 -19.4% 16,18 647 200 USD
2024-01-30 2024-01-29 VP Vente planifiée

Savill Corrine

Chief Business Officer

Dirigeant
40 000 -19.4%
14,09
563 600 USD 		40 000 -19.4% 14,09 563 600 USD
2024-01-24 2024-01-23 VP Vente planifiée

Savill Corrine

Chief Business Officer

Dirigeant
21 316 -11.4%
12,46
265 597 USD 		21 316 -11.4% 12,46 265 597 USD
2024-01-24 2024-01-22 VP Vente planifiée

Savill Corrine

Chief Business Officer

Dirigeant
4 125 -2.4%
12,02
49 583 USD 		4 125 -2.4% 12,02 49 583 USD
2024-01-24 2024-01-22 VP Vente planifiée

Savill Corrine

Chief Business Officer

Dirigeant
14 559 -7.9%
12,18
177 329 USD 		14 559 -7.9% 12,18 177 329 USD
2023-12-27 2023-12-26 V Vente

AHMED NADIM

President and CEO

Administrateur exécutif
4 272 -3.7%
9,24
39 473 USD 		4 272 -3.7% 9,24 39 473 USD
2023-12-22 2023-12-21 V Vente

Jones Jeffrey Alan

Chief Medical Officer

Dirigeant
1 860 -3.2%
8,50
15 810 USD 		1 860 -3.2% 8,50 15 810 USD
2023-12-22 2023-12-21 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
1 920 -2.2%
8,50
16 320 USD 		1 920 -2.2% 8,50 16 320 USD
2023-12-22 2023-12-21 V Vente

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
1 145 -1.3%
8,50
9 733 USD 		1 145 -1.3% 8,50 9 733 USD
2023-12-22 2023-12-21 V Vente

SUMER JACQUELYN L

Chief Legal Officer

Dirigeant
1 400 -3.1%
8,50
11 900 USD 		1 400 -3.1% 8,50 11 900 USD
2023-12-20 2023-12-18 V Vente

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
238 -0.3%
8,22
1 956 USD 		238 -0.3% 8,22 1 956 USD
2023-12-20 2023-12-18 V Vente

Jones Jeffrey Alan

Chief Medical Officer

Dirigeant
386 -0.7%
8,22
3 173 USD 		386 -0.7% 8,22 3 173 USD
2023-12-20 2023-12-18 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
398 -0.5%
8,22
3 272 USD 		398 -0.5% 8,22 3 272 USD
2023-12-20 2023-12-18 V Vente

SUMER JACQUELYN L

Chief Legal Officer

Dirigeant
290 -0.6%
8,22
2 384 USD 		290 -0.6% 8,22 2 384 USD
2023-12-13 2023-12-12 V Vente

Michaelson Jennifer

Chief Scientific Officer

Dirigeant
1 068 -1.2%
7,81
8 341 USD 		1 068 -1.2% 7,81 8 341 USD
2023-12-13 2023-12-12 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
1 926 -2.2%
7,81
15 042 USD 		1 926 -2.2% 7,81 15 042 USD
2023-06-29 2023-06-28 V Vente

AHMED NADIM

President and CEO

Administrateur exécutif
759 -0.7%
11,40
8 653 USD 		759 -0.7% 11,40 8 653 USD
2023-06-21 2023-06-20 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
399 -0.5%
12,94
5 163 USD 		399 -0.5% 12,94 5 163 USD
2023-06-21 2023-06-20 V Vente

SUMER JACQUELYN L

Chief Legal Officer

Dirigeant
291 -0.6%
12,94
3 766 USD 		291 -0.6% 12,94 3 766 USD
2023-06-21 2023-06-20 V Vente

Jones Jeffrey Alan

Chief Medical Officer

Dirigeant
387 -0.7%
12,94
5 008 USD 		387 -0.7% 12,94 5 008 USD
2023-06-21 2023-06-20 V Vente

Michaelson Jennifer

Chief Development Officer

Dirigeant
238 -0.3%
12,94
3 080 USD 		238 -0.3% 12,94 3 080 USD
2023-06-14 2023-06-12 V Vente

Michaelson Jennifer

Chief Development Officer

Dirigeant
176 -0.2%
13,11
2 307 USD 		176 -0.2% 13,11 2 307 USD
2023-06-14 2023-06-12 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
319 -0.4%
13,11
4 182 USD 		319 -0.4% 13,11 4 182 USD
2023-06-08 2023-06-07 VP Vente planifiée

Michaelson Jennifer

Chief Development Officer

Dirigeant
100 -0.1%
12,40
1 240 USD 		100 -0.1% 12,40 1 240 USD
2023-06-08 2023-06-06 VP Vente planifiée

Michaelson Jennifer

Chief Development Officer

Dirigeant
11 900 -11.6%
12,31
146 489 USD 		11 900 -11.6% 12,31 146 489 USD
2023-05-24 2023-05-23 V Vente

AHMED NADIM

President and CEO

Administrateur exécutif
707 -0.6%
9,15
6 469 USD 		707 -0.6% 9,15 6 469 USD
2023-05-19 2023-05-18 V Vente

Michaelson Jennifer

Chief Development Officer

Dirigeant
239 -0.3%
8,76
2 094 USD 		239 -0.3% 8,76 2 094 USD
2023-05-19 2023-05-18 V Vente

SUMER JACQUELYN L

Chief Legal Officer

Dirigeant
291 -0.6%
8,76
2 549 USD 		291 -0.6% 8,76 2 549 USD
2023-05-19 2023-05-18 V Vente

Jones Jeffrey Alan

Chief Medical Officer

Dirigeant
394 -0.7%
8,76
3 451 USD 		394 -0.7% 8,76 3 451 USD
2023-05-19 2023-05-18 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
399 -0.5%
8,76
3 495 USD 		399 -0.5% 8,76 3 495 USD
2023-05-16 2023-05-12 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
347 -0.4%
8,78
3 047 USD 		347 -0.4% 8,78 3 047 USD
2023-05-16 2023-05-12 V Vente

Michaelson Jennifer

Chief Development Officer

Dirigeant
193 -0.2%
8,78
1 695 USD 		193 -0.2% 8,78 1 695 USD
2023-04-26 2023-04-25 V Vente

AHMED NADIM

President and CEO

Administrateur exécutif
716 -0.6%
10,59
7 582 USD 		716 -0.6% 10,59 7 582 USD
2023-04-20 2023-04-18 V Vente

Michaelson Jennifer

Chief Development Officer

Dirigeant
238 -0.3%
10,71
2 549 USD 		238 -0.3% 10,71 2 549 USD
2023-04-20 2023-04-18 V Vente

Jones Jeffrey Alan

Chief Medical Officer

Dirigeant
392 -0.7%
10,71
4 198 USD 		392 -0.7% 10,71 4 198 USD
2023-04-20 2023-04-18 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
398 -0.5%
10,71
4 263 USD 		398 -0.5% 10,71 4 263 USD
2023-04-20 2023-04-18 V Vente

SUMER JACQUELYN L

Chief Legal Officer

Dirigeant
290 -0.6%
10,71
3 106 USD 		290 -0.6% 10,71 3 106 USD
2023-04-14 2023-04-12 V Vente

Michaelson Jennifer

Chief Development Officer

Dirigeant
176 -0.2%
10,22
1 799 USD 		176 -0.2% 10,22 1 799 USD
2023-04-14 2023-04-12 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
318 -0.4%
10,22
3 250 USD 		318 -0.4% 10,22 3 250 USD
2023-03-27 2023-03-23 V Vente

AHMED NADIM

President and CEO

Administrateur exécutif
706 -0.6%
10,51
7 420 USD 		706 -0.6% 10,51 7 420 USD
2023-03-27 2023-03-20 V Vente

SUMER JACQUELYN L

Chief Legal Officer

Dirigeant
305 -0.6%
11,32
3 453 USD 		305 -0.6% 11,32 3 453 USD
2023-03-27 2023-03-20 V Vente

Trigilio Jeffrey

Chief Financial Officer

Dirigeant
399 -0.5%
11,32
4 517 USD 		399 -0.5% 11,32 4 517 USD
2023-03-27 2023-03-20 V Vente

Jones Jeffrey Alan

Chief Medical Officer

Dirigeant
390 -0.7%
11,32
4 415 USD 		390 -0.7% 11,32 4 415 USD
2023-03-27 2023-03-20 V Vente

Michaelson Jennifer

Chief Development Officer

Dirigeant
238 -0.3%
11,32
2 694 USD 		238 -0.3% 11,32 2 694 USD
2022-11-29 2022-11-25 VP Vente planifiée

Michaelson Jennifer

See Remarks

Dirigeant
4 000 -7.0%
13,30
53 200 USD 		4 000 -7.0% 13,30 53 200 USD
2022-09-29 2022-09-27 VP Vente planifiée

Michaelson Jennifer

See Remarks

Dirigeant
4 000 -7.0%
12,40
49 600 USD 		4 000 -7.0% 12,40 49 600 USD
2022-08-09 2022-08-08 VP Vente planifiée

Michaelson Jennifer

Chief Development Officer

Dirigeant
1 385 -2.5%
15,01
20 789 USD 		1 385 -2.5% 15,01 20 789 USD
2022-08-04 2022-08-04 V Vente

F2 Vision SCS

Actionnaire important
25 989 -2.0%
14,31
371 788 USD 		25 989 -2.0% 14,31 371 788 USD
2022-08-04 2022-08-03 V Vente

F2 Vision SCS

Actionnaire important
19 129 -1.5%
14,24
272 334 USD 		19 129 -1.5% 14,24 272 334 USD
2022-08-04 2022-08-02 V Vente

F2 Vision SCS

Actionnaire important
4 792 -0.4%
14,10
67 554 USD 		4 792 -0.4% 14,10 67 554 USD
2022-07-26 2022-07-25 VP Vente planifiée

Michaelson Jennifer

Chief Development Officer

Dirigeant
8 000 -13.1%
14,51
116 080 USD 		8 000 -13.1% 14,51 116 080 USD
2022-07-21 2022-07-19 VP Vente planifiée

Savill Corrine

Acting Chief Business Officer

Dirigeant
14 958 -9.1%
15,22
227 661 USD 		14 958 -9.1% 15,22 227 661 USD
2022-07-21 2022-07-18 VP Vente planifiée

Savill Corrine

Acting Chief Business Officer

Dirigeant
5 042 -3.0%
15,06
75 933 USD 		5 042 -3.0% 15,06 75 933 USD
2022-07-12 2022-07-11 VP Vente planifiée

Savill Corrine

Acting Chief Business Officer

Dirigeant
200 -0.1%
13,85
2 770 USD 		200 -0.1% 13,85 2 770 USD
2022-07-12 2022-07-11 VP Vente planifiée

Savill Corrine

Acting Chief Business Officer

Dirigeant
39 800 -19.0%
13,33
530 534 USD 		39 800 -19.0% 13,33 530 534 USD
2022-06-23 2022-06-23 V Vente

F2 Bioscience I 2017 Ltd

Actionnaire important
29 631 -5.2%
13,00
385 310 USD 		29 631 -5.2% 13,00 385 310 USD
2022-06-23 2022-06-22 V Vente

F2 Bioscience I 2017 Ltd

Actionnaire important
49 953 -8.1%
12,70
634 578 USD 		49 953 -8.1% 12,70 634 578 USD
2022-06-23 2022-06-21 V Vente

F2 Bioscience I 2017 Ltd

Actionnaire important
22 319 -3.5%
12,77
284 929 USD 		22 319 -3.5% 12,77 284 929 USD
2022-06-07 2022-06-06 A Achat

AHMED NADIM

President and CEO

Administrateur exécutif
8 090 +inf%
12,40
100 316 USD 		8 090 +inf% 12,40 100 316 USD
// ... existing code ... // ... rest of the file ...